BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25034158)

  • 1. Systemic lupus erythematosus and malignancies: a review article.
    Tessier-Cloutier B; Clarke AE; Ramsey-Goldman R; Gordon C; Hansen JE; Bernatsky S
    Rheum Dis Clin North Am; 2014 Aug; 40(3):497-506, viii. PubMed ID: 25034158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the links between systemic lupus erythematosus and cancer.
    Bernatsky S; Ramsey-Goldman R; Clarke A
    Rheum Dis Clin North Am; 2005 May; 31(2):387-402, viii-ix. PubMed ID: 15922152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic lupus and malignancies.
    Bernatsky S; Kale M; Ramsey-Goldman R; Gordon C; Clarke AE
    Curr Opin Rheumatol; 2012 Mar; 24(2):177-81. PubMed ID: 22227880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased congenital heart defects in children born to women with systemic lupus erythematosus: results from the offspring of Systemic Lupus Erythematosus Mothers Registry Study.
    Vinet É; Pineau CA; Scott S; Clarke AE; Platt RW; Bernatsky S
    Circulation; 2015 Jan; 131(2):149-56. PubMed ID: 25355915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignancies in systemic lupus erythematosus: an update.
    Ladouceur A; Clarke AE; Ramsey-Goldman R; Bernatsky S
    Curr Opin Rheumatol; 2019 Nov; 31(6):678-681. PubMed ID: 31403485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of malignancy in women with systemic lupus erythematosus.
    Sweeney DM; Manzi S; Janosky J; Selvaggi KJ; Ferri W; Medsger TA; Ramsey-Goldman R
    J Rheumatol; 1995 Aug; 22(8):1478-82. PubMed ID: 7473469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The occurrence of malignancies in a Hungarian lupus population].
    Tarr T; Szekanecz E; Zeher M; Szegedi G; Kiss E
    Orv Hetil; 2006 Nov; 147(46):2229-33. PubMed ID: 17396395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there an association of malignancy with systemic lupus erythematosus? An analysis of 276 patients under long-term review.
    Sultan SM; Ioannou Y; Isenberg DA
    Rheumatology (Oxford); 2000 Oct; 39(10):1147-52. PubMed ID: 11035137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignancy in systemic lupus erythematosus: what have we learned?
    Bernatsky S; Ramsey-Goldman R; Clarke AE
    Best Pract Res Clin Rheumatol; 2009 Aug; 23(4):539-47. PubMed ID: 19591783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignancy in systemic lupus erythematosus: a nationwide cohort study in Taiwan.
    Chen YJ; Chang YT; Wang CB; Wu CY
    Am J Med; 2010 Dec; 123(12):1150.e1-6. PubMed ID: 21183006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung, liver, prostate, bladder malignancies risk in systemic lupus erythematosus: evidence from a meta-analysis.
    Ni J; Qiu LJ; Hu LF; Cen H; Zhang M; Wen PF; Wang XS; Pan HF; Ye DQ
    Lupus; 2014 Mar; 23(3):284-92. PubMed ID: 24429300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case-cohort study.
    Bernatsky S; Joseph L; Boivin JF; Gordon C; Urowitz M; Gladman D; Fortin PR; Ginzler E; Bae SC; Barr S; Edworthy S; Isenberg D; Rahman A; Petri M; Alarcón GS; Aranow C; Dooley MA; Rajan R; Sénécal JL; Zummer M; Manzi S; Ramsey-Goldman R; Clarke AE
    Ann Rheum Dis; 2008 Jan; 67(1):74-9. PubMed ID: 17545189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignancies in systemic lupus erythematosus.
    Kiss E; Kovacs L; Szodoray P
    Autoimmun Rev; 2010 Feb; 9(4):195-9. PubMed ID: 19643208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of clinical features and prognosis with age at disease onset in patients with systemic lupus erythematosus.
    Feng X; Zou Y; Pan W; Wang X; Wu M; Zhang M; Tao J; Zhang Y; Tan K; Li J; Chen Z; Ding X; Qian X; Da Z; Wang M; Sun L
    Lupus; 2014 Mar; 23(3):327-34. PubMed ID: 24297642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Cancer Risk Profile of Systemic Lupus Erythematosus Patients.
    Hardenbergh D; Naik R; Manno R; Azar A; Monroy Trujillo JM; Adler B; Haque U; Timlin H
    J Clin Rheumatol; 2022 Jan; 28(1):e257-e262. PubMed ID: 33657590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lupus and cancer.
    Gayed M; Bernatsky S; Ramsey-Goldman R; Clarke A; Gordon C
    Lupus; 2009 May; 18(6):479-85. PubMed ID: 19395448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term followup study in a Danish cohort.
    Dreyer L; Faurschou M; Mogensen M; Jacobsen S
    Arthritis Rheum; 2011 Oct; 63(10):3032-7. PubMed ID: 21953088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infections in systemic lupus erythematosus.
    Navarra SV; Leynes MS
    Lupus; 2010 Oct; 19(12):1419-24. PubMed ID: 20947551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are women with lupus at higher risk of HPV infection?
    Klumb EM; Pinto AC; Jesus GR; Araujo M; Jascone L; Gayer CR; Ribeiro FM; Albuquerque EM; Macedo JM
    Lupus; 2010 Nov; 19(13):1485-91. PubMed ID: 20605875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with abnormal Pap results in systemic lupus erythematosus.
    Bernatsky S; Ramsey-Goldman R; Gordon C; Joseph L; Boivin JF; Rajan R; Allen A; Moore AD; Leung MH; Clarke A
    Rheumatology (Oxford); 2004 Nov; 43(11):1386-9. PubMed ID: 15280571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.